Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 49

1.

Nuclear accumulation of cyclin D1 during S phase inhibits Cul4-dependent Cdt1 proteolysis and triggers p53-dependent DNA rereplication.

Aggarwal P, Lessie MD, Lin DI, Pontano L, Gladden AB, Nuskey B, Goradia A, Wasik MA, Klein-Szanto AJ, Rustgi AK, Bassing CH, Diehl JA.

Genes Dev. 2007 Nov 15;21(22):2908-22.

2.

Disruption of cyclin D1 nuclear export and proteolysis accelerates mammary carcinogenesis.

Lin DI, Lessie MD, Gladden AB, Bassing CH, Wagner KU, Diehl JA.

Oncogene. 2008 Feb 21;27(9):1231-42. Epub 2007 Aug 27.

3.

Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival.

Wiestner A, Tehrani M, Chiorazzi M, Wright G, Gibellini F, Nakayama K, Liu H, Rosenwald A, Muller-Hermelink HK, Ott G, Chan WC, Greiner TC, Weisenburger DD, Vose J, Armitage JO, Gascoyne RD, Connors JM, Campo E, Montserrat E, Bosch F, Smeland EB, Kvaloy S, Holte H, Delabie J, Fisher RI, Grogan TM, Miller TP, Wilson WH, Jaffe ES, Staudt LM.

Blood. 2007 Jun 1;109(11):4599-606. Epub 2007 Feb 13.

4.
5.

Identification of mutations that disrupt phosphorylation-dependent nuclear export of cyclin D1.

Benzeno S, Lu F, Guo M, Barbash O, Zhang F, Herman JG, Klein PS, Rustgi A, Diehl JA.

Oncogene. 2006 Oct 12;25(47):6291-303. Epub 2006 May 29.

PMID:
16732330
6.

Cyclin D1: polymorphism, aberrant splicing and cancer risk.

Knudsen KE, Diehl JA, Haiman CA, Knudsen ES.

Oncogene. 2006 Mar 13;25(11):1620-8. Review.

PMID:
16550162
7.

Cyclin D1b variant influences prostate cancer growth through aberrant androgen receptor regulation.

Burd CJ, Petre CE, Morey LM, Wang Y, Revelo MP, Haiman CA, Lu S, Fenoglio-Preiser CM, Li J, Knudsen ES, Wong J, Knudsen KE.

Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2190-5. Epub 2006 Feb 6.

8.

Expression of constitutively nuclear cyclin D1 in murine lymphocytes induces B-cell lymphoma.

Gladden AB, Woolery R, Aggarwal P, Wasik MA, Diehl JA.

Oncogene. 2006 Feb 16;25(7):998-1007.

9.

Location, location, location: the role of cyclin D1 nuclear localization in cancer.

Gladden AB, Diehl JA.

J Cell Biochem. 2005 Dec 1;96(5):906-13. Review.

PMID:
16163738
10.

Cyclins and cdks in development and cancer: a perspective.

Deshpande A, Sicinski P, Hinds PW.

Oncogene. 2005 Apr 18;24(17):2909-15. Review.

PMID:
15838524
11.

Phosphorylation of cyclin D1 at Thr 286 during S phase leads to its proteasomal degradation and allows efficient DNA synthesis.

Guo Y, Yang K, Harwalkar J, Nye JM, Mason DR, Garrett MD, Hitomi M, Stacey DW.

Oncogene. 2005 Apr 14;24(16):2599-612.

PMID:
15735756
12.

Overexpression of cyclin D1 in pancreatic beta-cells in vivo results in islet hyperplasia without hypoglycemia.

Zhang X, Gaspard JP, Mizukami Y, Li J, Graeme-Cook F, Chung DC.

Diabetes. 2005 Mar;54(3):712-9.

13.

Transcriptional regulation by a DNA-associated form of cyclin D1.

Bienvenu F, Barré B, Giraud S, Avril S, Coqueret O.

Mol Biol Cell. 2005 Apr;16(4):1850-8. Epub 2005 Jan 19.

14.

Minireview: Cyclin D1: normal and abnormal functions.

Fu M, Wang C, Li Z, Sakamaki T, Pestell RG.

Endocrinology. 2004 Dec;145(12):5439-47. Epub 2004 Aug 26. Review.

PMID:
15331580
15.

The activities of cyclin D1 that drive tumorigenesis.

Ewen ME, Lamb J.

Trends Mol Med. 2004 Apr;10(4):158-62.

PMID:
15059606
16.

Use of pyrosequencing to detect clinically relevant polymorphisms of genes in basal cell carcinoma.

Zhang Z, Liu W, Jia X, Gao Y, Hemminki K, Lindholm B.

Clin Chim Acta. 2004 Apr;342(1-2):137-43.

PMID:
15026274
17.

Enhanced tumor formation in cyclin D1 x transforming growth factor beta1 double transgenic mice with characterization by magnetic resonance imaging.

Deane NG, Lee H, Hamaamen J, Ruley A, Washington MK, LaFleur B, Thorgeirsson SS, Price R, Beauchamp RD.

Cancer Res. 2004 Feb 15;64(4):1315-22.

18.

An alternatively spliced cyclin D1 isoform, cyclin D1b, is a nuclear oncogene.

Lu F, Gladden AB, Diehl JA.

Cancer Res. 2003 Nov 1;63(21):7056-61.

19.

Cyclin D1 gene (CCND1) mutations in endometrial cancer.

Moreno-Bueno G, Rodríguez-Perales S, Sánchez-Estévez C, Hardisson D, Sarrió D, Prat J, Cigudosa JC, Matias-Guiu X, Palacios J.

Oncogene. 2003 Sep 4;22(38):6115-8.

PMID:
12955092
20.

Specificity of cyclin D1 for androgen receptor regulation.

Petre-Draviam CE, Cook SL, Burd CJ, Marshall TW, Wetherill YB, Knudsen KE.

Cancer Res. 2003 Aug 15;63(16):4903-13.

Supplemental Content

Support Center